|
業務類別
|
Biotechnology |
|
業務概覽
|
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses. |
| 公司地址
| 777 West 41st Street, Suite 401, Miami Beach, FL, USA, 33140 |
| 電話號碼
| +1 605 679-6980 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.sab.bio |
| 員工數量
| 63 |
| Dr. Christoph Lawrence Bausch, PhD |
Chief Operating Officer |
美元 412.20K |
02/06/2025 |
| Dr. Eddie J. Sullivan, PhD |
Director and President |
美元 480.90K |
02/06/2025 |
| Mr. Samuel J. Reich |
Chief Executive Officer and Chairman of the Board |
美元 518.30K |
02/06/2025 |
| Dr. Alexandra Kropotova, M.D. |
Chief Medical Officer and Executive Vice President |
美元 540.10K |
02/06/2025 |
| Ms. Lucy To |
Chief Financial Officer and Principal Accounting Officer |
美元 164.40K |
02/06/2025 |
|
|
| Mr. Andrew D. Moin |
Independent Director |
02/06/2025 |
| Admiral Scott Giberson, (Ret.),M.P.H.,R.Ph. |
Independent Director |
02/06/2025 |
| Dr. Eddie J. Sullivan, PhD |
Director and President |
02/06/2025 |
| Mr. David Link, M.B.A. |
Vice Chairman of the Board |
02/06/2025 |
| Dr. William J. Polvino, M.D. |
Independent Director |
02/06/2025 |
| Ms. Helen Katherine Ellias |
Independent Director |
02/06/2025 |
| Mr. Samuel J. Reich |
Chief Executive Officer and Chairman of the Board |
02/06/2025 |
| Mr. Erick J. Lucera, C.F.A. |
Independent Director |
02/06/2025 |
| Dr. David Zaccardelli, Pharm.D. |
Director |
07/01/2026 |
| Dr. Rita I. Jain, M.D. |
Director |
07/01/2026 |
| Dr. Jay S. Skyler,M.D.,M.A.C.P. |
Director |
02/06/2025 |
|
|
|
|
